A commentary  criticized our systematic review regarding the use of direct-acting agents (DAAs) in chronic hepatitis C . The following represents our major disagreements. Sustained virological response (SVR) is a non-validated surrogate outcome. The principles of evidence-based medicine require that it be validated in randomized clinical trials (RCTs) by showing parallel benefits in clinical outcomes . This article is protected by copyright. All rights reserved.